Opthea Stock

Opthea Employees 2025

Opthea Employees

5

Ticker

OPT.AX

ISIN

AU000000OPT2

WKN

A2AB8J

In 2025, Opthea employed 5 people, a 0% change from the 5 number of employees in the previous year.

Opthea Aktienanalyse

What does Opthea do?

Opthea Ltd is a biopharmaceutical company specializing in the development of novel therapies for various eye diseases. The company was founded in 1985 in Melbourne, Australia as a spin-off from the Burnet Institute for Medical Research and Public Health. Since then, Opthea has become a leading company in ophthalmology and is researching innovative therapies that have the potential to improve the lives of millions of patients worldwide. Opthea's business model is to develop novel therapies for various eye diseases and market these therapies through partnerships with established pharmaceutical companies. The company focuses on developing therapies based on the inhibition of growth factors and other signaling pathways that promote the development of abnormal blood vessels and inflammation. This therapeutic principle offers a promising way to effectively treat various eye diseases. Opthea specializes in developing therapies for the treatment of wet age-related macular degeneration (AMD), which is the leading cause of severe visual impairment in older people. Opthea is developing a therapy aimed at inhibiting the excessive formation of blood vessels in the macula of the eye, which can impair vision. The drug called OPT-302 is used in combination therapies with existing treatments for wet AMD and has the potential to slow down the progression of the disease and improve vision. In addition to the therapy for wet AMD, Opthea is also researching therapy options for other eye diseases such as diabetic retinopathy, retinal vein occlusion, and corneal diseases. Opthea has filed numerous patents in this field and collaborates with various academic and clinical partners to advance the development of innovative therapies. Another important component of Opthea's business model is collaboration with established pharmaceutical companies. In 2020, Opthea entered into a licensing agreement with the pharmaceutical company Novartis, which includes exclusive distribution and marketing rights for the drug OPT-302 in Europe, Japan, and other countries outside of North America. This partnership allows Opthea to benefit from collaboration with an experienced and established partner while maximizing the potential of its innovative therapy. In summary, Opthea is a promising company in ophthalmology that specializes in the development of innovative therapies for various eye diseases. The company works closely with academic and clinical partners and leverages the advantages of partnerships with established pharmaceutical companies to maximize the potential of its therapies. With the therapy for wet AMD already in the pipeline, Opthea is expected to develop further therapy options in the future that will contribute to improving the lives of millions of patients worldwide. Opthea ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Opthea's Employee Base

Opthea's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Opthea's operational capacity and future potential.

Year-to-Year Comparison

Assessing Opthea's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Opthea's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Opthea’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Opthea stock

How many employees does Opthea have this year?

Opthea has 5 undefined employees this year.

How many employees did Opthea have compared to the previous year?

Compared to the previous year, Opthea had 0% more employees.

What impact did the number of employees have on the company Opthea?

The number of employees has a direct impact on the efficiency and productivity of Opthea. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Opthea?

The number of employees can also have an impact on investors of Opthea, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Opthea affect the company?

An increase in equity of Opthea can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Opthea's equity affect the company?

A reduction in equity of Opthea can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Opthea?

Some factors that can influence the equity of Opthea include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Opthea so important for investors?

The equity of Opthea is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Opthea influence the company?

The number of employees at Opthea can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Opthea evolved in recent years?

In recent years, the number of employees at Opthea has changed by 0.

How many employees does Opthea currently have?

Opthea currently has 5 undefined employees.

Why is the number of employees important for investors of Opthea?

The number of employees is important for investors of Opthea as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Opthea take to change the number of employees?

To change the number of employees, Opthea can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Opthea pay?

Over the past 12 months, Opthea paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Opthea is expected to pay a dividend of 0 USD.

What is the dividend yield of Opthea?

The current dividend yield of Opthea is .

When does Opthea pay dividends?

Opthea pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Opthea?

Opthea paid dividends every year for the past 0 years.

What is the dividend of Opthea?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Opthea located?

Opthea is assigned to the 'Health' sector.

Wann musste ich die Aktien von Opthea kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Opthea from 2/24/2005 amounting to 0.15 USD, you needed to have the stock in your portfolio before the ex-date on 2/4/2005.

When did Opthea pay the last dividend?

The last dividend was paid out on 2/24/2005.

What was the dividend of Opthea in the year 2024?

In the year 2024, Opthea distributed 0 USD as dividends.

In which currency does Opthea pay out the dividend?

The dividends of Opthea are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Opthea

Our stock analysis for Opthea Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Opthea Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.